Claritin Vs. Singulair

Featured Article

The U.S. Food and Drug Administration (FDA) has turned down an application for a combo allergy drug. The medication would have combined the allergy medication Claritin with the asthma, allergy drug Singulair. Drugmakers Merck and Schering-Plough issued statements that they were still evaluating the FDA's response. Experts stress that both medications will continue to be offered separately.

Read more

More information on "Claritin Vs. Singulair"

From Our Experts

See more SharePosts »

From Our Sources

More on Asthma »